Monica M Farley

Author PubWeight™ 187.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 15.48
2 Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005 12.75
3 Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010 8.37
4 Burden of Clostridium difficile infection in the United States. N Engl J Med 2015 8.17
5 Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006 7.68
6 Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007 6.45
7 Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008 6.13
8 Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006 5.56
9 FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis 2004 5.53
10 The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007 5.36
11 Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005 5.29
12 Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009 4.38
13 Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002 4.08
14 Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003 3.54
15 Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004 3.05
16 Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011 2.99
17 Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006 2.93
18 Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013 2.78
19 Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009 2.56
20 Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009 2.53
21 Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence. Clin Infect Dis 2005 2.43
22 Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis 2011 1.91
23 Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012 1.91
24 Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis 2004 1.85
25 FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother 2010 1.79
26 Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 2012 1.68
27 Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol 2010 1.57
28 Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis 2004 1.55
29 Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun 2005 1.53
30 Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008 1.51
31 Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003 1.48
32 Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. Clin Infect Dis 2014 1.47
33 Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002 1.47
34 Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis 2011 1.42
35 Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis 2012 1.34
36 Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 2003 1.34
37 Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health 2010 1.33
38 Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol 2007 1.33
39 Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS 2010 1.32
40 NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014 1.31
41 Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis 2012 1.26
42 Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010 1.26
43 Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2009 1.25
44 Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 2005 1.23
45 Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol 2009 1.20
46 Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008 1.19
47 Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis 2002 1.16
48 Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011 1.15
49 Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005 1.15
50 Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis 2003 1.13
51 Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Pediatr Infect Dis J 2015 1.12
52 Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect 2010 1.12
53 Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis 2013 1.11
54 Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J 2013 1.10
55 Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infect Immun 2003 1.07
56 Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic. J Infect Dis 2012 1.06
57 Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infect Immun 2003 1.05
58 Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013 1.03
59 Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic. Clin Infect Dis 2012 1.02
60 Clostridium difficile infection among children across diverse US geographic locations. Pediatrics 2014 1.01
61 Population-based surveillance for Yersinia enterocolitica infections in FoodNet sites, 1996-1999: higher risk of disease in infants and minority populations. Clin Infect Dis 2004 1.00
62 Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011 0.99
63 A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality. Infect Control Hosp Epidemiol 2007 0.99
64 Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J 2009 0.97
65 Invasive pneumococcal pneumonia and respiratory virus co-infections. Emerg Infect Dis 2012 0.97
66 Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. J Infect Dis 2013 0.96
67 Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period. Vaccine 2012 0.92
68 The burden of influenza hospitalizations in infants from 2003 to 2012, United States. Pediatr Infect Dis J 2014 0.91
69 Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J Infect Dis 2013 0.90
70 Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis 2003 0.89
71 Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis 2002 0.89
72 An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One 2012 0.89
73 Association of IS1016 with the hia adhesin gene and biotypes V and I in invasive nontypeable Haemophilus influenzae. Infect Immun 2008 0.88
74 Lack of heteroresistance among Staphylococcus aureus isolates with vancomycin MICs of 2 micrograms per milliliter by automated testing. J Clin Microbiol 2009 0.87
75 Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a. Clin Vaccine Immunol 2010 0.85
76 Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. J Infect 2012 0.84
77 Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis 2015 0.83
78 Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2014 0.83
79 Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med 2009 0.82
80 Invasive infection with multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 among HIV-infected adults. Clin Infect Dis 2005 0.81
81 Twenty Years of Active Bacterial Core Surveillance. Emerg Infect Dis 2015 0.81
82 Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerg Infect Dis 2015 0.79
83 Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites. Emerg Infect Dis 2015 0.79
84 Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral. Clin Vaccine Immunol 2011 0.79
85 Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study. Pediatr Infect Dis J 2014 0.77
86 Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillance network sites. Clin Infect Dis 2013 0.76